Oragenics, Inc. is a pharmaceutical company based in Alachua, FL, specializing in the development of brain-related drugs and medical technologies to address unmet clinical needs and tap into significant market opportunities.
The company is currently preparing for Phase II clinical trials to treat concussions, showcasing their commitment to cutting-edge research and innovation in the field of medical technology.
Generated from the website